Aug 2013 - Global Lifesciences Business in India- News & Updates


Top Highlights for August 2013:  (Please click on news title to view details)

 

  1. Smith & Nephew has $1.5 billion for acquisitions in US, India, China, Brazil and Russia
  2. Claris Life Sciences, India completes transfer of its infusion business; receives $161 million (Rs. 1,050 Cr)
  3. After acquiring L&T’s medical equipment business, India based Skanray Tech, set to raise funds worth $10.70 million (Rs.70 Cr) for overseas acquisitions
  4. India based Metropolis, enters Kenyan market with aSh40 million Lab, to further invest Sh490 Million in 5 years
  5. India based ReaMetrix acquired by Beckman Coulter LS, US for an undisclosed amount
  6. India,Germany to initiate joint research in Health & Biomedical Sciences under National funding programmes 
  7. India based $1.74 bn Lupin acquires US rights to market Romark Laboratories’s anti-diarrhea drug to augment their growth and profitability
  8. India's Venus Remedies bags marketing rights to grab maximum share in the $270 million meropenem market in EU;aims to penetrate the market in 15 more countries by Q1 2014
  9. $6.x billion Mylan makes India its largest product sourcing base owing to more than 60% cost advantage and its 10000+ strong workforce in India
  10. Everist Genomics targets markets in India, Canada & Europe for its exponential growth

 

Aagami - Company Updates:

  1. Aagami CEO Mr. Dinesh Jain to attend BioPharm America 2013 this September in Boston, MA

Please Note: Aagami has moved to a new office!

        We are pleased to announce that we have moved to a new office located at:

        2135 City Gate Lane, Suite 300                         
        Naperville IL 60563

 

       The new development will enable the company to accommodate its clients more

       effectively and efficiently.

×
Twitter